Trial intelligence / Profile preview

Cold Stored Platelets in Traumatic Brain Injury

NCT04726410Phase 2Completed

Start
Mar 2022
Primary completion
May 2024
Modality
Tissue Cells
Countries
1
01

Overview

Phase 2, randomised, open-label trial of cold-stored platelet concentrate in traumatic brain injury (TBI). Primary endpoint: Study Feasibility at 6 months. Started Mar 2022; status: completed.

02

Drugs

cold-stored platelet concentrate
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT04726410.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04726410.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call